exposure to different microbiologically produced enzymes have been described repeatedly. For example, detergent industry workers were often sensitised to proteolytic enzymes produced by Bacillus subtilis.1-3 Sensitisation to trypsin, papain, and pancreatic extracts has also been reported.'
Immediate type allergy with positive skin prick tests as well as positive radioallergosorbent tests (RAST) have been found, indicating the presence of specific IgE antibodies. 235 The ability of industrially used proteolytic enzymes to induce precipitating antibodies and allergic alveolitis has also been discussed. Some precipitins have been supposed to be of nonimmunological origin, but IgG antibodies specific to enzyme preparations of Bacillus subtilis and papain have been demonstrated by radioimmunological techniques. 2567 The presence of IgG antibodies is presumed to be an indication of exposure to enzyme rather than being related to disease. 5 Industrial fungal oa-amylase is an enzyme produced from a strain of Aspergillus oryzae. It hydrolyses glucosidic linkages in starch and is used in the baking industry to supplement flour for yeast leavened dough. This enzyme causes respiratory tract allergy in subjects with positive skin prick test. The first report, in 1979, was from an enzyme handling factory. 8 Recently, circulating IgE antibodies against aamylase have been found in sera from bakers. Positive skin prick tests and bronchial challenges were reported in a few cases. 9 10 In this paper we present four index cases and a cross sectional survey, all from the same factory in which x-amylase was handled, confirming the allergenic potency of this enzyme.
This factory produces semimanufactured products for restaurants and bakeries. The employees handle potential industrial allergens such as egg and milk powder, and wheat, malt, and soya flour as well as fungal a-amylase. About 10 different bread mixes and dough improvers are produced. Fungal a-amylase from two different sources is added to these mixes. The a-amylase content of the dough improvers and bread mixes is usually less than 1%. Because of these findings we conducted the present survey, which aimed to evaluate the health hazard related to a-amylase and other airborne allergens in this factory.
Subjects
The survey comprised all 20 persons exposed to fungal a-amylase in the factory. Sixteen workers were exposed during mixing and packing operations and four during laboratory work. All nine persons manufacturing margarine in another part of the factory building served as referents. Skin prick tests were carried out with the following common inhalation allergens having an extract potency corresponding to 10 000 BU (= 10 HEP): birch, timothy, Dactylis, and mugworth pollens, D pteronyssinus, D farinae, Aspergillus fumigatus, Cladosporium, cat, dog, and horse danders, a control dilution, and histamine dihydrochloride solution at 10 mg/ml. " Skin tests were also performed with eight factory products as allergens at a concentration of 1:20 w/v. These were wheat, rye, soya, and malt flour, milk, egg white, whole egg powder, and fungal aamylase at 50 mg/ml, all diluted in saline with 50% glycerol and 0-5% phenol. After 15 minutes the weal reaction was graded in comparison with the histamine standard, which was evaluated as a + ++ -reaction.
Skin prick testing with the amylase solution was also performed in a sample of 25 consecutive patients seen in the Occupational Allergy Unit at the Asthma and Allergy Research Centre. All these tests were negative.
SEROLOGICAL ANALYSES
Concentration of IgE antibodies to a-amylase was measured by RAST. A commercial fungal x-amylase (NOVO industries, Bagsvaerd, Denmark) was conjugated to cyanogen bromide activated cellulose discs according to standard procedures. A 125I labelled anti-IgE preparation (Pharmacia, Uppsala, Sweden) employed in our common RAST routine, was used as a tracer." The lower limit for a positive test was defined according to the Phadebas RAST reference system (Pharmacia Diagnostics, Uppsala, Sweden).
The concentrations of total circulating IgE were determined by the paper radioimmunosorbent test (PRIST; Pharmacia, Uppsala, Sweden) and were expressed as kU/l serum. Values higher than 100 kU/l were regarded as raised.
Precipitating antibodies were assayed by diffusing 15 M1 fungal a-amylase at a concentration of 1-0 mg/ml against a serum well containing 0-2 ml human serum in agarose gel for three days. Brisman, Belin Countercurrent electrophoresis in agarose at pH 8 6, a more sensitive gel based analytical method for the detection of precipitating antibodies, was employed using a-amylase at 10 mg/ml and a twofold dilution series of each worker's serum.
Concentration of IgG antibodies to a-amylase was also measured by an enzyme linked immunosorbent assay (ELI SA) technique employing peroxidase conjugated rabbit antihuman IgG (Dako-Immunoglobulins AS, Copenhagen, Denmark). The absorbance at 450 nm of a serum dilution of 1:20 was recorded. An absorbance ofmore than 0 5 was defined as positive.
CHALLENGE TESTS
All workers with positive skin prick tests to aamylase (except one, excluded due to pregnancy) underwent nasal challenge tests with fungal amylase. After spraying a saline aerosol in one nostril, 0;2 ml amylase solution at a concentration of 1 0 mg/ml was sprayed in the same nostril. The challenge continued with a 10-fold increase of concentration until a positive reaction was achieved or until a concentration of 100 mg/ml was reached.
The response was measured by weighing the amount of nasal secretion, by recording subjective symptoms such as nasal blockage, itching and number of sneezes, and by posterior rhinomanometry. Rhinomanometric results were expressed as the gradient (in degrees) of the flow pressure curve generated during tidal expiration through the challenged nasal cavity. The challenge was regarded as positive if 01 g or more of nasal secretion was found together with an increase of more than 50% in the measured nasal resistance. ' 
Results
Work related symptoms such as rhinitis and dermatitis were reported by 11 ofthe 20 amylase exposed workers (table 2) . Symptoms suggesting work related asthma were not reported. The occurrence of work related symptoms was significantly more common in the exposed subjects than in the referents (p < 0 01). Six of the exposed workers showed a positive skin prick test to amylase; two of them were also positive to malt flour and one to several different flours.
Spirometry was normal in all but five cases with previously known disease. The means of FEV, and FVC as per cent ofpredicted values were 95 and 96% in the exposed group and 100 and 96% in the referents, a difference not statistically significant. Table 3 describes workers with positive skin prick tests to a-amylase. All three workers with positive skin prick tests to common allergens as well as to aamylase had raised total IgE concentrations whereas those with positive skin prick tests only to amylase had normal IgE concentrations. Smoking habits were not different in those workers who were skin prick test positive to a-amylase and those who were not.
By immunodiffusion analysis, precipitating antibodies to ax-amylase were demonstrated in the sera of two exposed non-symptomatic workers. Countercurrent electrophoresis showed titres of 1:64 and 1:128 in those two workers. One other serum, which showed a weak precipitin reaction, was positive with a titre of 1:4. These three sera were also positive in an ELISA IgG antibody test using xamylase as a coating antigen. Four more sera were positive only in the countercurrent electrophoresis with titres between 1:1 and 1:8. The figure shows the good agreement between the countercurrent electrophoresis and the ELISA test results (r = 0-82, p < 0o001).
a-Amylase nasal challenge tests were regarded as clearly positive in three out of six tested workers (table 4) .
Discussion
The experience of four index cases from one factory appearing with asthma, or rhinitis, or both at the outpatients' department gave reason to suspect that fungal a-amylase powder is a potent occupational allergen. These suspicions have now been confirmed by results from this cross sectional study of workers from the same factory.
From the index cases we realised that previous severe allergic reaction to a-amylase-that is, asthma-forced the affected workers to leave the aamylase exposed jobs. Accordingly, it could be anticipated that a cross sectional study would disclose only upper respiratory tract symptoms of sensitisation.
We found a significantly higher prevalence ofnasal and skin symptoms among workers exposed to aamylase compared with referents. These a-amylase exposed workers were temporarily exposed to high total dust concentrations during mixing and packing. Correlation between a-amylase antibody determination using countercurrent electrophoresis and IgG-ELISA absorbance (correlation coefficient r = 0-82, p < 0 001). This study also provides a possibility to compare the allergenic potency of ai-amylase with the potency of well known flour allergens, because all workers exposed to ot-amylase are also exposed to different flours. In fact the bread mixes and dough improvers mainly consist of flour. The exposure to flour should be more than 100 times greater than that of acamylase. Nevertheless, a positive skin prick test reaction to cereal extracts was seen in only three workers compared with twice as many workers who were positive to fungal a-amylase. In summary the study showed a high prevalence of rhinitis and dermatitis among workers producing aamylase containing "bread improvers". It is concluded that a-amylase is a potent sensitiser, much more potent than cereal flours. It is assumed that bakers are also at risk of being sensitised and precautions should be taken when handling axamylase powder.
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